f Abstract Pyridoxal phosphate (PLP)-dependent enzymes are unrivaled in the diversity of reactions that they catalyze. New structural data have paved the way for targeted mutagenesis and mechanistic studies and have provided a framework for interpretation of those results. Together, these complementary approaches yield new insight into function, particularly in understanding the origins of substrate and reaction type specificity. The combination of new sequences and structures enables better reconstruction of their evolutionary heritage and illuminates unrecognized similarities within this diverse group of enzymes. The important metabolic roles of many PLP-dependent enzymes drive efforts to design specific inhibitors, which are now guided by the availability of comprehensive structural and functional databases. Better understanding of the function of this important group of enzymes is crucial not only for inhibitor design, but also for the design of improved protein-based catalysts.
INTRODUCTION
Following its identification in 1951 as one of the active vitamers of vitamin B 6 (1), pyridoxal 5Ј-phosphate (PLP) has been the subject of extensive research directed toward understanding its unequaled catalytic versatility. 1 As a result, the basic mechanisms of PLP-assisted reactions, both in solution and enzymeassociated, have been well characterized and are now a staple of biochemistry textbooks (for example, see 2, 3) . A number of reviews have addressed the subject in greater detail, and readers are directed particularly to the recent articles by Hayashi (4) and John (5) . Transaminases, edited by Christen & Metzler (6) , remains an excellent and thorough source of information about these enzymes. More detailed reviews concentrate on the function of a number of specific enzymes, including tryptophan synthase (7), O-acetylserine sulfhydrylase (8) , ␦-aminolevulinate synthase (9) , serine hydroxymethyltransferase (SHMT) (10) , and branched chain amino acid aminotransferase (BCAT) (11) .
In addition to their versatility as catalysts, PLP-dependent enzymes have attracted attention because of their widespread involvement in cellular processes. These enzymes are principally involved in the biosynthesis of amino acids and amino acid-derived metabolites, but they are also found in the biosynthetic pathways of amino sugars (12) and other amine-containing compounds. Their importance is further underscored by the number identified as drug targets. For example, inhibitors of ␥-aminobutyric acid aminotransferase (GABA ATase) are used in the treatment of epilepsy (13) , SHMT has been identified as a target for cancer therapy (14) , and inhibitors of ornithine decarboxylase (ODC) are employed in the treatment of African sleeping sickness (15) . Functional defects in PLP enzymes have furthermore been implicated in a number of disease pathologies, including homocystinuria, which is most frequently caused by mutations in cystathionine ␤-synthase (16, 17) .
Despite the long history of research in the field, we are only now beginning to answer some of the most exciting questions. In particular, technological advances that have allowed ever more rapid determination of enzyme structures and the accumulation of large sequence databases have also enhanced our understanding of enzymatic catalysis. Analyses of sequences and structures yield significant insight regarding the evolution of this diverse class of enzymes. Additionally, crystal structures elegantly demonstrate how PLP enzymes harness the potential of the cofactor to accelerate the rates only of specific reactions, and they provide the basis for targeted mutagenesis.
This review describes many of the new insights that have come from recent structural and mechanistic studies, with a primary focus on determinants of substrate specificity and reaction type, as well as the design of inhibitors for this class of enzyme. The mechanisms and structures are briefly discussed to provide background.
MECHANISTIC VERSATILITY OF PLP
PLP-catalyzed reaction types can be divided according to the position at which the net reaction occurs. Reactions at the ␣ position include transamination, decarboxylation, racemization, and elimination and replacement of an electrophilic R group. Those at the ␤ or ␥ position include elimination or replacement. Examples of each of these reactions are shown in Scheme 1, and the basic mechanisms are shown in Schemes 2 (␣) and 3 (␤ and ␥). Exceptions to these common types include the formation of a cyclopropane ring from S-adenosyl-Lmethionine (SAM), catalyzed by 1-aminocyclopropane-1-carboxylate (ACC) synthase (18) , and the cleavage of ACC to ␣-ketobutyrate and ammonia, catalyzed by ACC deaminase (19) ; these are not discussed here. Because many of the reaction pathways share common intermediates, a number of enzymes also catalyze reactions that are combinations of the basic types, such as the decarboxylation-dependent transamination (aminoisobutyrate ϩ pyruvate 3 acetone ϩ CO 2 ϩ L-Ala) catalyzed by dialkylglycine decarboxylase (DGD; 20) or the ␥-elimination and ␤-replacement (O-phospho-L-homoserine ϩ H 2 O 3 L-Thr ϩ P i ) catalyzed by threonine synthase (21) .
Although the scope of PLP-catalyzed reactions initially appears to be bewilderingly diverse, there is a simple unifying principle. The cofactor in all cases functions to stabilize negative charge development at C ␣ in the transition state that is formed after condensation of the amino acid substrate with PLP to form a Schiff base (referred to as the external aldimine). 2 The fully formed carbanion 2 There are two exceptions to this basic principle. The glycogen phosphorylase family of enzymes utilizes the phosphate group of PLP for catalysis [reviewed in (106) ], and the aminomutase family catalyzes a radical-initiated reaction on PLP-bound amino acid substrates [reviewed in (107) ]. Neither of these families will be discussed in this review.
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PYRIDOXAL PHOSPHATE ENZYMES Scheme 1 Examples of each of the common reaction types catalyzed by PLP-dependent enzymes. Net changes at the ␣ carbon (top) include racemization, decarboxylation, ␣-elimination and replacement, and transamination. Net changes at the ␤ carbon (middle) include ␤-elimination or replacement, and those at the ␥-carbon (bottom) are ␥-replacement or elimination. The basic mechanisms for these reactions are shown in Schemes 2 and 3.
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ELIOT y KIRSCH is referred to as the quinonoid intermediate (Scheme 4). The pK a for loss of the C ␣ -proton from an amino acid in the absence of PLP is ϳ 30 (22) ; therefore, that anion, formation of which is required in order to enable all of the described chemistry, is ordinarily inaccessible under physiological conditions. 3 The stabilization of the C ␣ -anion is facilitated by delocalization of the negative charge through the pi system of the cofactor, and for this reason PLP is often described as an electron sink. This factor allows PLP in the absence of enzyme to catalyze many of the possible reactions slowly (reviewed in 6). The function of the protein apoenzyme, therefore, is to enhance this innate catalytic potential and to enforce selectivity of substrate binding and reaction type. In most cases, this selectivity is exquisite-potential side reactions are limited to barely detectable levels.
STRUCTURAL DIVERSITY
Although PLP enzymes were for a time underrepresented in protein structure databases (5), the situation has been rectified in recent years, as an abundance of new structures have been solved. It was initially postulated that the structures of PLP enzymes would correlate with the reaction type (24) , but it has since been found that each of the major structural classes contains representatives of multiple reaction types, the evolutionary implications of which are discussed below. All PLP enzymes whose structures have been solved to date belong to one of five fold types, which have been described in detail in two recent reviews (25, 26) , and therefore are only briefly summarized here. Figure 1 shows single representatives of Fold Types I-IV, whose mechanisms are discussed in this review.
The majority of known structures are of Fold Type I (aspartate aminotransferase family) enzymes, a group that includes many of the best-characterized PLP enzymes. They invariably function as homodimers or higher-order oligomers, with two active sites per dimer. The active sites lie on the dimer interface, and each monomer contributes essential residues to both active sites. In general, the two active sites are independent, but asymmetry has been observed in a few cases. Negative cooperativity, for example, has been reported in GABA ATase, where a dimer with two functional active sites exhibits the same specific activity as a dimer with only one functional active site (27) . The two active sites in each dimer of glutamate-1-semialdehyde aminomutase also exhibit different reactivities, as evidenced by the biphasic kinetics of reduction of the enzyme-PLP aldimine by sodium borohydride (28) . Each monomer of Fold Type I enzymes has a large and a small domain. In a number of cases [e.g., aspartate aminotransferase (AATase)], these domains move significantly upon association with substrate, creating a closed conformation that may contribute to the specificity for both the substrate and the reaction type (see below).
The structures of Fold Type II (tryptophan synthase family) enzymes are similar to those of Fold Type I, but the proteins are evolutionarily distinct (29) . One significant difference is that the active sites of Fold Type II enzymes are composed entirely of residues from one monomer [first observed in tryptophan synthase (30) ]. Nevertheless, the functional form remains a homodimer or higher-order oligomer. These enzymes also differ from those of Fold Type I in that they often contain additional regulatory domains. Examples include threonine synthase (31) and cystathionine ␤-synthase (32), which are allosterically regulated by SAM, and threonine deaminase, which is regulated by isoleucine and valine (reviewed in 33).
The Fold Type IV (D-amino acid aminotransferase family) enzymes are superficially similar to Fold Types I and II, in that they are also functional homodimers, and the catalytic portion of each monomer is composed of a small and a large domain. The cofactor is bound in a site that is a near mirror image of the Fold Types I and II binding sites, so that the re rather than si face is solvent exposed (34) .
Fold Types III (alanine racemase family) and V (glycogen phosphorylase family) are strikingly different from the other PLP enzymes. The Fold Type V enzymes are mechanistically distinct in utilizing the phosphate group of the cofactor for catalysis and are not considered further. The Fold Type III enzymes consist of a classical ␣/␤ barrel and a second ␤-strand domain. Interestingly, the mode of binding of PLP is similar to that of other fold types, with the phosphate 4 ™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™ Scheme 2 Examples of mechanisms of reactions involving net change at the ␣ position. All reactions are shown starting with the substrate aldimine, which is formed by transaldimination of the lysine-bound PLP. Racemization: the bacterial alanine racemase utilizes a tyrosine residue (51, 104) to deprotonate L-alanine, forming the quinonoid intermediate, which is reprotonated by a lysine residue on the opposite face of the cofactor to produce D-alanine. Decarboxylation: the reaction begins with loss of CO 2 from the substrate aldimine, producing the quinonoid intermediate. Protonation by an unidentified active site residue in ornithine decarboxylase generates the product aldimine. ␣-Replacement: the well-studied serine hydroxymethyltransferase (10) initiates the retro-aldol cleavage of serine by deprotonation of the hydroxyl group. Formaldehyde is released to generate the quinonoid intermediate. Protonation of the quinonoid at C ␣ by the lysine produces the product aldimine of glycine. Transamination: the first half-reaction catalyzed by tyrosine aminotransferase involves initial proton abstraction from the glutamate aldimine at C ␣ by the active site lysine, yielding the quinonoid intermediate. Reprotonation at C 4 Ј of the cofactor by that lysine generates the ketimine intermediate, which is subsequently hydrolyzed to release ␣-ketoglutarate, leaving the enzyme in the PMP form. A complete catalytic cycle involves subsequent reaction with hydroxyphenylpyruvate to give tyrosine and to regenerate the PLP form of the enzyme.
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PYRIDOXAL PHOSPHATE ENZYMES group anchored at the N terminus of an ␣Ϫhelix, H-bond interactions made to the 3Ј-OH, and the presence of the ubiquitous lysine Schiff base. Furthermore, these enzymes are also obligate dimers, as each monomer contributes residues to both active sites (35) .
Multiple scaffolds have clearly evolved to bind PLP and to assist in catalysis by this cofactor. In no case does the fold type dictate the reaction type, as each fold type contains multiple reaction types, and all common reaction types are found in at least two fold types. 4 Although only one racemase structure has been solved (alanine racemase Fold Type III), serine racemase is predicted to be in Fold Type II based on sequence (36) , and the fungal alanine racemase in Fold Type I (37).
Scheme 4
The primary function of PLP is to stabilize anions generated at C ␣ . The negative charge is delocalized by resonance in the pi system of the cofactor in the quinonoid intermediate after loss of a proton from the external aldimine.
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Scheme 3
Examples of mechanisms of reactions at the ␤ and ␥ positions. ␤-Replacement: tryptophan synthase (7) catalyzes a net ␤-replacement by first deprotonating the serine aldimine at C ␣ , producing the quinonoid intermediate. Protonation of the hydroxyl group by the active site lysine promotes its elimination, generating the aminoacrylate aldimine. Indole adds to C ␤ to form a second quinonoid that is subsequently protonated at C ␣ to generate the product aldimine. ␥-Replacement: in the cystathionine ␥-synthase-catalyzed ␥-replacement reaction (105) , O-succinyl homoserine is deprotonated at C ␣ to produce the quinonoid intermediate that is subsequently protonated at C 4 Ј of the cofactor to give the ketimine intermediate. Proton abstraction at C ␤ by an unknown active site base results in elimination of the succinyl group, which may occur in either a step-wise or concerted (shown) manner. Michael addition of cysteine to the ␤,␥-unsaturated ketimine and subsequent proton transfers yield a second quinonoid intermediate that is protonated at C ␣ to form the product aldimine. 
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DETERMINANTS OF REACTION TYPE Dunathan Stereoelectronic Hypothesis
Well before the lack of correlation between fold type and reaction type was recognized, much research was directed toward understanding the determinants of reaction type specificity. Dunathan postulated in 1966 (38) that the topology of the amino acid aldimine determined the bond to C ␣ that would be broken. He suggested that that bond must be situated so that it will align perpendicularly with the pyridine ring of the cofactor in the transition state of the reaction (Scheme 5). The ensuing carbanion is stabilized by conjugation with the extended pi system. This hypothesis was later confirmed when the structure of the aspartate aminotransferase/phosphopyridoxyl aspartate complex was solved (39) . All subsequently determined structures are consistent with this idea. Of particular interest in this respect are enzymes that catalyze C ␣ -deprotonation and decarboxylation at different points during their catalytic cycle.
8-AMINO-7-OXONONANOATE SYNTHASE (AONS)
AONS, the second of four enzymes in the biotin biosynthetic pathway, catalyzes the decarboxylation and addition of a pimeloyl group to alanine (Scheme 6). Interestingly, the reaction mechanism involves initial deprotonation rather than decarboxylation (40) . The quinonoid thus formed attacks pimeloyl-CoA, forming a ␤-keto acid intermediate, which is decarboxylated and reprotonated to form the product aldimine (Scheme 7). Decarboxylation of a ␤-keto acid is a facile reaction that may not require the participation of the cofactor, but the observation of the expected quinonoid intermediate indicates that it is likely involved (41) . Although no structure is available of the intermediate aldimine formed prior to decarboxylation, the structure of the product aldimine shows that pimeloyl addition occurs Scheme 5 The Dunathan stereoelectronic hypothesis. Substrates are bound to PLP such that the bond to C ␣ that is to be broken is aligned with the pi orbitals of the cofactor. Control of the substrate orientation thus enables the enzyme to distinguish between, for example, decarboxylation and deprotonation.
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ELIOT y KIRSCH on the face opposite from that of deprotonation, resulting in the carboxylate group occupying nearly the same position as that previously held by the proton (Scheme 7).
DIALKYLGLYCINE DECARBOXYLASE (DGD)
DGD is both an aminotransferase and a decarboxylase. A complete catalytic cycle involves decarboxylation and transamination of dialkylglycine to generate a ketone product and the pyridoxamine phosphate (PMP) form of the enzyme followed by reaction with pyruvate in a typical transamination to generate alanine and to restore the PLP form of the enzyme (Scheme 8). Structural and mechanistic studies demonstrated that the decarboxylation of the dialkyl amino acids is forced by large side chains, which are not accommodated in the same site as the methyl side chain of alanine. They instead occupy the same position as the alanine carboxylate. This reorientation results in the scissile bond being that between C ␣ and the carboxylate rather than that between C ␣ and the proton (42) (Scheme 9). Thus decarboxylation is prefered over deprotonation.
These examples demonstrate how PLP enzymes can strictly control the initial bond-breakage step and limit other potential reactions by restricting the bound substrate to a specific orientation. Control of the steps subsequent to the initial bond breakage is less well understood. C ␣ -deprotonation, for example, can lead to ␤-or ␥-elimination/replacement, racemization, or transamination (Schemes 2, 3). To promote the desired reaction, an enzyme must rigorously govern the electron flow and proton transfers. The structures of PLP enzymes have shown how active site residues are positioned to promote particular reaction types and to restrict possible side reactions. These principles are readily appreciated through a comparison of the structures of enzymes catalyzing transamination to that of a racemase.
Transamination
The first structures of a PLP-dependent enzyme to be determined were of the mitochondrial and cytosolic aspartate aminotransferases (AATase) (39, 43, 44) . They explained much of the available mechanistic data and inspired fruitful Scheme 6 The reaction catalyzed by 8-amino-7-oxononanoate synthase. The carboxylate group of alanine is replaced by a pimeloyl moiety. The mechanism of this reaction is shown in Scheme 7.
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PYRIDOXAL PHOSPHATE ENZYMES targeted mutagenesis investigations (45) (46) (47) (48) (49) . The electron sink nature of the cofactor is enhanced by a close interaction of the pyridinium nitrogen with an aspartate residue (D222), which acts to maintain the cofactor in the protonated form (Scheme 10). The displaced Schiff base lysine residue (K258) is positioned to transfer a proton to and from C ␣ and C 4 Ј. Since the substrates of AATase, aspartate and glutamate, cannot undergo ␤-or ␥-elimination, the primary side reaction that must be minimized is racemization. This objective is achieved by closure of the enzyme around the substrate, so that solvent water molecules do not access the quinonoid intermediate to protonate the re face (50). Furthermore, there are no active site acids in position to donate a proton to the re face of that intermediate. Subsequently solved structures of other aminotransferases con-
Scheme 7
The mechanism of the 8-amino-7-oxononanoate synthase-catalyzed reaction. The alanine aldimine is initially deprotonated, and the resulting quinonoid attacks the pimeloyl CoA thioester. Addition of the pimeloyl group to the face opposite from the deprotonation event causes the carboxylate to reorient perpendicular to the pyridine ring, resulting in subsequent decarboxylation. Protonation of this second quinonoid produces the product aldimine. Adapted from Reference 41.
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ELIOT y KIRSCH firmed that these are general properties of the entire class of enzymes. The D-amino acid aminotransferase (Fold Type IV) is particularly interesting because its active site is in part a mirror image of the L-amino acid aminotransferases (34) , in that the active site lysine is positioned on the re face and the si face is solvent exposed, neatly accounting for its opposite stereospecificity.
Scheme 8
The reaction catalyzed by dialkylglycine decarboxylase. In the first half-reaction, a dialkyl substrate is decarboxylated and transaminated, producing CO 2 , a ketone, and the PMP form of the enzyme. The latter form subsequently reacts with pyruvate in a transamination half-reaction to give alanine and to restore the PLP form of the enzyme.
Scheme 9
Steric control of reaction type by dialkylglycine decarboxylase. The three substituents on C ␣ occupy distinct binding sites, labeled A, B, and C. Whereas the A and B sites are tolerant of carboxylates and hydrogen or large alkyl groups, respectively, the C site only accommodates small alkyl groups. Amino acid substrates with small side chains, such as alanine, bind preferably with their carboxylate moieties in the B site, placing the C ␣ -proton in the reactive A site. Substrates with a large side chain (such as the phenylglycine shown), however, bind with that group in the B site, forcing the carboxylate into the reactive A site. For this reason, the distinction between decarboxylation or deprotonation is a consequence of the substrate structure. Adapted from Reference 42.
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Racemization
Although the structure of alanine racemase (ALR) from Bacillus stearothermophilus (51) is the only one presently available, the catalytic mechanism is apparent from the unique architecture of its active site. An active site Brønsted acid is expected to be on the opposite re face to complement the lysine on the si face, and a tyrosine provides this function here (Scheme 2). Like AATase, ALR acts on substrates incapable of undergoing elimination; therefore, the primary side reaction that must be limited is transamination. A major factor in promoting that restriction is likely the arginine that replaces the aspartate near the pyridinium nitrogen (Scheme 10). The positively charged arginine prevents protonation of the cofactor (51), thereby negating its electron sink properties. Although it might be expected that this interaction would also impair the normal function of the enzyme, the racemization reaction may require less delocalization of electron density into the cofactor. In this regard, it is notable that some known amino acid racemases do not require a cofactor (see Footnote 1). Although racemization is generally presumed to proceed through a fully formed carbanion at C ␣ (52), the instability of this species elicits consideration of an S E 2 mechanism where the incoming proton develops some bonding with C ␣ in a concerted transition state. Jencks pointed out (53) that stepwise mechanisms are generally preferred because of entropy considerations, but that mechanisms become concerted when the intermediate that would develop in the stepwise process is too unstable to exist.
Interestingly, some of the insights gained from this structure cannot be generally applied to all PLP-dependent racemases. Paiardini et al. (54) reported Scheme 10 Control of the electron sink properties of PLP by the amino acid side chain positioned nearest to the pyridinium nitrogen atom. An aspartate residue occupies this locus in aspartate aminotransferase and all other known Fold Type I enzymes, thereby maintaining ring protonation. The corresponding residue is an arginine in the bacterial alanine racemase, which is expected to maintain the cofactor in the unprotonated form. Lack of a proton at this position would greatly diminish the electron withdrawing properties of PLP.
an alanine racemase that is predicted to be a member of Fold Type I and to have an aspartate residue that interacts with the pyridinium nitrogen, as do all other Fold Type I enzymes.
Role of the Closed Conformation
Although it is not clear if the observed conformational changes of PLP enzymes contribute to substrate specificity (see below), the existence of the closed conformation undoubtedly contributes to reaction type specificity. Wolfenden pointed out the advantages of a closed conformation that makes more contacts with the bound substrate than are possible in a conformation from which the substrate must be able to dissociate (55) . The closed conformation can favor specific reactions by providing greater control over proton transfers and solvent accessibility. A well-studied example is serine hydroxymethyltransferase, which catalyzes a variety of side reactions (transamination, decarboxylation, racemization, etc.) when presented with substrates other than serine. The open form of the enzyme is unable to discriminate between the various reaction types in the way that the closed form can (37, 56) . Therefore, these reactions occur, at least in part, because the substrates in question do not induce the closed conformation.
DETERMINANTS OF SUBSTRATE SPECIFICITY
Role of the Closed Conformation
The potential contribution of induced fit to enzymatic substrate specificity has been much debated (for a recent overview, see 57), but it is now accepted that a conformational change induced only by certain substrates does not necessarily result in increased specificity for those substrates. Thus, it has been argued that the conformational change observed in AATase and many other PLP enzymes does not contribute to their substrate specificities (4). Exceptions to the general rule, however, include cases where substrate association or product dissociation is rate-determining for good substrates, whereas chemistry is rate-determining for poor substrates (58) . Since it has been shown that release of the product oxalacetate is partially rate determining for the reaction of AATase with aspartate and ␣-ketoglutarate (␣KG) (59), AATase is an example of an induced fit enzyme in which the conformational change may contribute to substrate specificity. It is not yet clear whether this conclusion extends to other PLP enzymes.
Dual Specificity of Aminotransferases
The basis for the dual specificity of aminotransferases has been elucidated by recent structural information. Because the aminotransferase reaction requires two different substrates to bind in succession to the same cofactor in the active site, these enzymes must be able to accommodate both structures while discriminating 399 PYRIDOXAL PHOSPHATE ENZYMES against all others. One possible solution would be for the PLP itself to move between two different substrate binding sites, but such movement has never been observed. An alternative is to take advantage of flexible side chains to position the functional groups into exclusive binding sites. This is the case for histidinol phosphate aminotransferase, which reacts with both histidinol phosphate and glutamate. The recently solved structures of substrate complexes of this enzyme (60) show that, although the phosphate and carboxylate groups interact primarily with the same arginine residue, the side chains of the two substrates have separate binding sites (Scheme 11).
Most known aminotransferases, however, adopt strategies for binding both substrates in the same site. Because many use the common substrate glutamate (thereby linking other amino acids to the cellular nitrogen pool), the problem of dual specificity is generally that of accommodating the negatively charged ␥-carboxylate of glutamate in a site that must also accept a neutral or positively charged side chain. Two common solutions to this problem have been found: the use of an arginine switch and an extended hydrogen bond network.
ARGININE SWITCHES
The first example of an arginine switch was observed in an engineered enzyme that was constructed by introducing six mutations into AATase. These changes resulted in a substantial increase in activity toward aromatic substrates (61) . The subsequent determination of the structure of the Scheme 11 Dual specificity of histidinol phosphate aminotransferase. The phosphate and carboxylate moieties of glutamate and histidinol phosphate, respectively, bind in the same site, although an additional arginine does interact with the phosphate group. In contrast, the oppositely charged imidazole and carboxylate side chains occupy spatially distinct sites and interact with different active site residues. The enzyme thus recognizes each substrate specifically. Adapted from Reference 60.
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ELIOT y KIRSCH mutant enzyme (62) showed that the large aromatic substrates are accommodated by movement of Arg292 out of the active site. Dicarboxylate substrates bind their ␤-or ␥-carboxylate via direct interaction with this arginine through a bidentate hydrogen bond/ion pair in the canonical AATase conformation (Scheme 12). The position of Arg292 is locked in AATases; therefore, substrates lacking a carboxylate side chain are effectively excluded.
More recently, directed evolution techniques have been utilized to broaden the substrate specificity of AATase to include branched chain (63) or aromatic amino acids (64) . Crystal structures of mutants with increased activity toward branched chain amino acids (65, 66) indicated that they also have acquired the ability to switch Arg292 out of the active site when uncharged substrates are bound, indicating that this trait is easily induced in AATase and is crucial for dual specificity.
Arginine switches are not unique to engineered enzymes. Tyrosine (aromatic) aminotransferase (TATase) is a well-characterized Fold Type I enzyme that has natural specificity for the aromatic amino acids tyrosine, phenylalanine, and tryptophan, as well as for the dicarboxylic amino acids aspartate and glutamate. A number of structures are now available of the Paracoccus denitrificans TATase that clearly demonstrate the arginine switch (67, 68) .
Crystallographic and modeling studies illuminated a similar strategy employed by the GABA (69, 70) and ornithine (71) aminotransferases, which react with both Scheme 12 Schematic of the arginine switch in aminotransferases that react with both dicarboxylic and aromatic amino acids. The ␥-carboxylate of glutamate (left) interacts closely with Arg292. This residue reorients to point out of the active site when aromatic substrates bind (right). This movement allows the enzyme to accept both types of substrates. Adapted from Reference 62.
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-amino acid substrates and the common substrate glutamate. GABA ATase, like AATase and TATase, binds the dicarboxylic acid substrate via two conserved arginines. The carboxylate of the -amino acid, GABA, occupies the same position as the ␥-carboxylate of glutamate, thereby taking advantage of the similar distance between the amino and carboxylate groups of GABA and the amino and ␥-carboxylate groups of glutamate. The second arginine (equivalent to Arg386 of AATase) moves to interact with a conserved glutamate near the active site (Scheme 13).
HYDROGEN BOND NETWORKS
Arginine switches, however, are not ubiquitous, even among TATases. Early sequence alignments indicated that a subgroup of aminotransferases (designated I␥) lack an Arg292 equivalent (72). The only structure available for a TATase of this group is that of the unliganded Pyrococcus horikoshii enzyme (73) . Modeling of the substrates in the active site suggests that this enzyme binds glutamate via an extended hydrogen-bonding network, as has been observed in the AATase from this same organism (74) (Scheme 14). The absence of a positively charged residue in this TATase makes it much easier to accommodate the uncharged substrates by simple rearrangement of the hydrogen bond network. Moreover, absence of the flexible arginine side chain allows this enzyme to distinguish between glutamate and aspartate. The specificity ratio (k cat /K m Glu )/(k cat /K m Asp ) for the P. horikoshii TATase is 3400 (73), compared to 0.27 for the Escherichia coli TATase (75), a typical member of the I␣ family.
Scheme 13
Schematic of the arginine switch in GABA aminotransferase. As in the case of AATase, GABA ATase binds the dicarboxylic acid substrate glutamate via two conserved arginines. In order to accommodate GABA, Arg445 moves away from the cofactor to engage in a salt bridge with a nearby glutamate residue. Adapted from References 69 and 70.
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ELIOT y KIRSCH The recently solved structures of the natural E. coli branched chain amino acid aminotransferase (BCAT) (76) show that this enzyme also takes advantage of different hydrogen bond interactions. BCAT reacts with the branched chain aliphatic amino acids isoleucine, leucine, and valine, as well as with glutamate. The hydrophobic substrates and glutamate all bind in the same site, which is a hydrophobic pocket consisting largely of aromatic residues. In contrast to the TATases, there is no large-scale rearrangement of the H-bond network to accommodate the charged substrate. Instead, the glutamate side chain, which is slightly longer than that of the other substrates, extends into a pocket where four residues (Arg97, Tyr31, Tyr129, and the backbone amide of Val109) hydrogen bond to the carboxylate. The arginine in this case forms only a monodentate interaction rather than the bidentate H-bond network seen in other enzymes, and it is extensively H-bonded to neighboring residues, allowing it to remain in position when the small hydrophobic substrates are bound (Scheme 15).
EVOLUTION
Evolutionary relationships among PLP-dependent enzymes have been extensively examined (25, 29, 72) . The following discussion is therefore limited to recent insights emanating from the increased number of available structures.
Scheme 14
Dual substrate specificity can also be achieved by hydrogen bond rearrangement. Pyrococcus horikoshii TATase binds the ␥-carboxylate of glutamate via a hydrogen bond network rather than an arginine residue. Direct interactions are made with a threonine residue and a tightly bound water molecule. Modeling of bound tyrosine suggests that the hydrogen bond network rearranges, so that the aromatic ring stacks against a nearby tyrosine residue, as well as makes a hydrogen bond to the same threonine residue that is involved in glutamate association. Adapted from References 73 and 74.
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The analyses of sequences and structures that led to the categorization of PLP enzymes into the five recognized fold types also indicated that the fold types are evolutionarily distinct (29) . The similarities of the cofactor binding sites thus provide an excellent example of convergent evolution. It is believed that reaction type generally evolved first within each fold type, followed by narrowing substrate specificity (29) . A number of enzymes, however, group most closely with those that catalyze reactions of a different type, suggesting that their reaction type-specificity arose later in evolution. In these cases, the change in reaction type can often be explained as a consequence of altered substrate specificity. For example, enzymes catalyzing ␤-elimination are found in many evolutionary subgroups, often among enzymes that catalyze transamination or ␥-elimination. Since ␤-elimination of a good leaving group is a very facile reaction, it is easy to imagine that the acquisition of improved binding of a substrate with a ␤ leaving group could readily lead to a change in the reaction specificity to favor elimination. Another example of an enzyme where a substrate specificity change effects a change in reaction type is dialkylglycine decarboxylase (see above). DGD is fundamentally an aminotransferase like most of its closest evolutionary relatives, but it also catalyzes decarboxylation of dialkyl substrates that bind in a unique orientation.
Scheme 15
Dual substrate recognition by branched chain amino acid aminotransferase. The substrate binding pocket is composed primarily of aromatic residues, and the hydrophobic substrate isoleucine is surrounded by five of them, only three of which are shown (Phe36, Tyr164, and Tyr31). The longer glutamate substrate extends far enough to form hydrogen bonds with the hydroxyl groups of two tyrosines and the guanidino group of an arginine residue. Note that the orientation of the substrate C ␣ -H bond is opposite that found in other fold types. Adapted from Reference 76.
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ELIOT y KIRSCH L-Threonine-O-3-phosphate decarboxylase, an enzyme that is also most closely related to aminotransferases, is unusual because the change in reaction type from transamination to decarboxylation requires a different substrate orientation with respect to the cofactor, and therefore mandates substantial rearrangement of the substrate binding mode. How this change was achieved evolutionarily is evident in the fact that the closest evolutionary relative of the enzyme is histidinol-phosphate aminotransferase, which has evolved to bind a phosphate group in the position usually occupied by the substrate carboxylate. One can imagine that from this starting point (or something similar), it is easy to improve binding of threonine-phosphate in the same site. With the phosphate as an anchor point in the usual carboxylate site, the carboxylate is positioned for bond breakage (Scheme 16). It is not clear, however, how decarboxylationdependent transamination is averted, but presumably the mechanism is similar to those of other decarboxylases and is related to the lack of a proton on the active site lysine after decarboxylation. Solvent exclusion can also prevent hydrolysis of the ketimine intermediate formed by protonation at C 4 Ј (78).
Possibly the most interesting group of PLP enzymes from an evolutionary standpoint is that of Fold Type IV (D-amino acid aminotransferase (DAAT) family). This family is unique in containing both a D-amino acid and an L-amino acid aminotransferase (the previously described BCAT). Since the active site lysine can only catalyze proton transfer on one face (79) , DAAT and BCAT must bind their substrates in opposite orientations (Scheme 17), as evidenced in the crystal structures of these enzymes (76, 80) . Either the binding mode of the Scheme 16 Possible evolutionary route to threonine phosphate decarboxylase. Histidinol phosphate aminotransferase is quite similar to Fold Type I amino acid aminotransferases and must share a common ancestral aminotransferase. However, it acquired additional affinity for a phosphate group. Relatively minor changes are required for that enzyme to accommodate threonine phosphate. With the large phosphate group as an anchor, the carboxylate is forced into the position occupied by the C ␣ proton in the related aminotransferases, thereby effecting a change in the reaction type from transamination to decarboxylation.
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PYRIDOXAL PHOSPHATE ENZYMES substrate was reversed at some point during evolution, or the enzymes share a common ancestor with broad specificity.
MECHANISMS OF INHIBITION
The prominent role of PLP enzymes in metabolism has generated a great deal of interest in the mechanisms of their inhibition. Although they, like nearly all enzymes, are susceptible to simple competitive inhibition, the catalytic versatility of the cofactor enhances their potential susceptibility to natural or designed mechanism-based inhibitors. Because such inhibition is often irreversible, it is of much greater practical utility than competitive inhibition (81) . The inhibited complexes are also particularly useful for crystallographic studies, as they often mimic substrate or reaction intermediate complexes. A large number of inhibitors of PLP enzymes have now been identified (for more detailed reviews, see 6, 82), and they have been generally grouped into three categories according to their mode of inactivation.
Noncovalent Inactivation
The simplest mechanism-based inhibitors of PLP enzymes are those that form exceptionally stable complexes that often resemble normal reaction intermediates. Although the inhibitor is covalently bound to the cofactor, the affinity for the protein is through noncovalent interactions. The combined affinity may be very high. 
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ELIOT y KIRSCH aminotransferases but not in the ACC synthase-catalyzed elimination reaction; thus the enzyme is unable to catalyze its hydrolysis. Of particular interest is the subset of these inhibitors whose stability is the result of enzyme-catalyzed aromatization. An example is the inhibition of GABA ATase by (S)-4-amino-4,5-dihydro-2-thiophenecarboxylic acid (84) (Scheme 19). Since the products of these reactions are not covalently attached to the enzyme, the inhibited enzymes can often be reactivated by dialysis in the presence of PLP, so that the PLP-inhibitor species is replaced with fresh PLP (for example, see 83) , but this mode of reactivation does not generally occur on a physiologically relevant timescale.
Scheme 18
Inhibition of 1-aminocyclopropane-1-carboxylate synthase by aminoethoxyvinylglycine. The inhibitor reacts to form a stable ketimine that is not hydrolyzed and remains tightly bound to the enzyme. Dissociation by dialysis removes the cofactor together with the covalently bound inhibitor (83) .
Scheme 19
Inhibition of ␥-aminobutyrate aminotransferase by (S)-4-amino-4,5-dihydro-2-thiophenecarboxylic acid. The reaction proceeds identically to the aminotransferase reaction up to the formation of the ketimine intermediate. At this point, deprotonation of a ␤ carbon yields a very stable aromatic product that does not react further and remains in the active site (84) .
PYRIDOXAL PHOSPHATE ENZYMES
Activated Nucleophiles
A number of amino acids with good ␤-leaving groups, such as ␤-chloroalanine, inhibit several types of PLP enzymes (6) . The general mechanism for this reaction is by initial formation and release of an enamine intermediate, which is a potent nucleophile and can attack C 4 Ј of the cofactor (85) (Scheme 20). Inactivation is irreversible, because the cofactor remains covalently bound to the enzyme. An alternative proposed inactivation pathway (86) is by direct Michael addition of an active site nucleophile to the aminoacrylate aldimine. Free aminoacrylate can also diffuse out of the enzyme (as it does in natural ␤-elimination reactions), where it spontaneously decomposes to pyruvate and ammonia, leaving the enzyme in an active form. Because of this possibility of turnover as well as inhibition, the effectiveness of these inhibitors is often quantitated by the inactivation/turnover ratio. 
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ELIOT y KIRSCH The vinylglycine ketimine can also be hydrolyzed to release the potentially toxic Michael acceptor 2-ketobut-3-enoic acid, leaving the enzyme in the PMP form (92) . Effective inhibitor design requires limiting these possible alternative pathways.
Reversible Competitive Inhibition
Competitive inhibitors have proven to be exceptionally useful in studies of enzyme function and as unreactive substrate mimics in crystallographic studies. There are two general classes of competitive inhibitors-those that bind noncovalently and those that react reversibly with the enzyme to form an aldimine that does not react further. A classical example of the former is maleate, which inhibits AATase by binding in the aspartate site (6) . This association induces closure of the enzyme into the active form; thus this inhibitor has proven useful for crystallographic studies of this form of the enzyme.
The most common of the inhibitors that form unreactive aldimines are ␣-methyl substrate analogs and amino-oxy or hydrazine analogs. The close similarity of the ␣-methyl compounds to the substrates makes them particularly useful for crystallography, and structures of complexes of AATase and phosphoserine aminotransferase with ␣-methylaspartate and ␣-methylglutamate, respectively, have been reported (93) (94) (95) . Recent examples of the use of aminooxy compounds for structure determination are those of ACC synthase with the amino-oxy analogue of SAM (96) (Scheme 23) and of ornithine aminotransferase with L-canaline, an analogue of ornithine (97) (Scheme 23). The amino-oxy adducts with PLP are sufficiently stable so that these compounds often need not be substrate analogs. Hydroxylamine itself binds to AATase to form a PLPoxime whose K i ϭ 700 nM, a figure less than that for any of the dicarboxylic inhibitor complexes (6) . A final example of an inhibitor that forms an unreactive aldimine is that of 1-aminoethyl phosphonate (AlaP), which binds tightly to alanine 
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ELIOT y KIRSCH racemase (98) . Although this molecule has a C ␣ proton, it does not undergo deprotonation. The stability of this complex enabled determination of the enzyme structure with the inhibitor in the active site, providing a mimic of the complex with the natural substrate (99) .
The Challenge of Inhibitor Specificity
Although the variety of possible mechanisms of inhibition makes it easy to design effective inhibitors, specificity remains as a major challenge for use in vivo. Gabaculine (Scheme 23), for example, is a potent inhibitor of GABA ATase and also inhibits the closely related ornithine aminotransferase (100), making it unsuitable for pharmaceutical applications. One promising approach is to incorporate the reactive functional groups described above in structures that are very close substrate analogs. An example is ␥-vinylGABA (vigabatrin; Scheme 23), a specific inhibitor of GABA ATase, which is used in the treatment of epilepsy (reviewed in 101). In this case, the vinylic group is appended to the natural substrate GABA to form a potential electrophile analogous to vinylglycine. Another example is the ornithine aminotransferase (OAT) inhibitor 5-fluoromethylornithine (102) (Scheme 23). The fluoride ion is susceptible to ␤-elimination, which generates an enamine capable of nucleophilic attack on the cofactor in the manner described above (71, 103) , while the ornithine scaffold provides OAT specificity.
Understanding mechanisms of inhibition is crucial not only to enable the design of better inhibitors, but also to understand the control of reaction mechanisms by this important class of enzymes. It is also of interest to ask how enzymes whose natural reaction pathways include reactive intermediates, such as the aminoacrylate aldimine and vinylglycine ketimine, manage to avoid inactivation.
CONCLUSIONS
The recent effusion of X-ray structures for PLP-dependent enzymes-more than twice as many were deposited in the protein data bank between 1997 and 2001 as in the preceding five years-has done much to provide a visual framework in
Scheme 23
The structures of the inhibitors gabaculine, vigabatrin, 5-fluoromethylornithine, canaline, and amino-oxy SAM.
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PYRIDOXAL PHOSPHATE ENZYMES which the mechanistic concepts secured over the past half-century can be interpreted. The findings served to focus more penetrating targeted mutagenesis experiments and, taken together with those from newer studies capitalizing upon directed evolution methods, helped to elucidate some of the fundamental principles of protein design.
We now have a good understanding of the mechanisms of dual substrate recognition by aminotransferases and of how the fates of the common C ␣ anion are directed. Many questions remain unanswered, particularly with regard to the control of reaction pathways of both natural substrates and mechanism-based inhibitors. Of the four fold types, only Fold Type I is well represented in the structural database, and many of the reaction types are only represented by one or two structures. We need additional structures of underrepresented fold types in order to direct further functional studies. The understanding of the substrate and reaction type-specificity of PLP enzymes is crucial for the design not only of specific and medicinally useful inhibitors, but also of improved protein-based catalysts.
